TY  - GEN
AU  - Müller-Wieland,D
TI  - [New, expensive antidiabetics for the treatment of type-2 diabetes--pro]
SN  - 1439-4413
PY  - 2010///0517
KW  - Blood Glucose
KW  - metabolism
KW  - Cost-Benefit Analysis
KW  - statistics & numerical data
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Drug Approval
KW  - economics
KW  - Drug Costs
KW  - Evidence-Based Medicine
KW  - Germany
KW  - Humans
KW  - Hypoglycemia
KW  - Hypoglycemic Agents
KW  - adverse effects
KW  - National Health Programs
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1055/s-0030-1253679
ER  -